# Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)

> **NCT02171988** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 150 (actual)

## Conditions studied

- Postural Orthostatic Tachycardia Syndrome

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Bisoprolol
- **DRUG:** Propranolol+pyridostigmine
- **DRUG:** Bisoprolol+pyridostgmine

## Key facts

- **NCT ID:** NCT02171988
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-02
- **Final completion:** 2016-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02171988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02171988, "Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02171988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*